Developing novel blood-stage malaria vaccines
<p>Natural exposure to Plasmodium falciparum’s asexual blood-stage results in protection against severe disease, but no vaccine using the widely-studied blood-stage antigens apical membrane antigen 1 (AMA1) or merozoite surface protein 1 (MSP1) has proven convincingly protective in clinical tr...
Κύριος συγγραφέας: | Douglas, AD |
---|---|
Άλλοι συγγραφείς: | Draper, SJ |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2015
|
Θέματα: |
Παρόμοια τεκμήρια
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
ανά: Kapulu, MC
Έκδοση: (2014) -
Enhancing the efficacy of viral vector blood-stage malaria vaccines
ανά: Forbes, E
Έκδοση: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
ανά: Elias, SC
Έκδοση: (2014) -
Liver-stage vaccines for malaria
ανά: Longley, RJ
Έκδοση: (2013) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
ανά: Bauza, K
Έκδοση: (2012)